Skip to content

Clover Health Investments CLOV Q4 2024 Annual earnings

Reported March 11, 2025 · Before market open

Revenue$337.0MMiss by $10.4M
EPS-$0.04Beat by $0.03
Revenue estimate$347.4M
EPS estimate-$0.07

Next report

Aug 5, 2026 (In 1 week)
Revenue estimate$728.3M
EPS estimate$0.05

Financials

Q4 2024

Income statement

See full
Revenue$337.0M+7.9%
Operating income-$21.4M+66.0%
Net income-$22.1M+68.7%
EPS (diluted)-$0.04+71.4%

Balance sheet

See full
Cash & equivalents$194.5M+10.2%
Total debt$3.3M-28.7%
Total equity$341.1M+19.1%
Total assets$580.7M+1.8%

Cash flow

See full
CapEx$315.0K

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$1.58B+244%
Enterprise value$1.39B+384%
P/S1.2×+0.8×

Profitability

See full
Operating margin-3.3%-1.5pp
Net margin-3.1%-1.4pp

Returns & leverage

See full
Return on equity-13.7%-6.1pp
Debt / equity0.0×
Current ratio1.6×0.0×

Versus estimates

Ask the moment Clover Health Investments reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Clover Health Investments report Q4 2024 earnings?
Clover Health Investments (CLOV) reported Q4 2024 earnings on March 11, 2025 before market open.
What were Clover Health Investments's Q4 2024 revenue and EPS?
Clover Health Investments reported revenue of $337.0M and eps of $-0.04 for Q4 2024.
Did Clover Health Investments beat estimates in Q4 2024?
Revenue missed the consensus estimate of $347.4M by $10.4M. EPS beat the consensus estimate of $-0.07 by $0.03.
Where can I find Clover Health Investments's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001801170-25-000052) directly on SEC EDGAR. The filing index links above go to sec.gov.